Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-25-005064
Filing Date
2025-11-14
Accepted
2025-11-14 16:30:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10064
  Complete submission text file 0000902664-25-005064.txt   11834
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Subject) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-59149 | Film No.: 251487068
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address WHITELEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR
Business Address WHITELEY CHAMBERS DON STREET ST. HELIER Y9 JE2 4TR (212) 729-7524
Darwin Global Management, Ltd. (Filed by) CIK: 0001839209 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A